Legend Biotech (LEGN) Receivables - Other (2019 - 2024)
Legend Biotech (LEGN) reported Receivables - Other of $780000.0 for Q4 2024, down 1.27% on a YoY basis from $790000.0 in Q1 2024, and down 1.27% quarter-over-quarter from $790000.0 in Q4 2023.
Legend Biotech (LEGN) Receivables - Other (2019 - 2024) Analysis & Trends
Legend Biotech has reported Receivables - Other for 6 years, with the latest figure at $780000.0 in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other fell 1.27% year-over-year to $780000.0; the trailing twelve-month figure through Dec 2024 stood at $780000.0 (down 1.27% YoY), and the FY2024 full-year result was $780000.0, down 1.27% from the prior year.
- Receivables - Other for Q4 2024 stood at $780000.0, down from $790000.0 in the prior quarter.
- The five-year high for Receivables - Other was $948000.0 in Q4 2022, with the low at $619000.0 in Q4 2020.
- Historically, Receivables - Other has averaged $794800.0 across 5 years, with a median of $790000.0 in 2023.
- Annual changes were most pronounced in 2020 — Receivables - Other surged 565.59% — and 2023, when it slipped 16.67%.
- Legend Biotech's Receivables - Other stood at $619000.0 in 2020, then surged by 35.22% to $837000.0 in 2021, then grew by 13.26% to $948000.0 in 2022, then fell by 16.67% to $790000.0 in 2023, then retreated by 1.27% to $780000.0 in 2024.
- The last three Receivables - Other figures came in at $780000.0 (Q4 2024), $790000.0 (Q4 2023), and $948000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Dec 31, 2022 | 948,000.00 |
| Dec 31, 2022 | 948,000.00 |
| Dec 31, 2021 | 837,000.00 |
| Dec 31, 2021 | 837,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Dec 31, 2019 | 93,000.00 |
| Dec 31, 2019 | 93,000.00 |